Hydroxy tipelukast

• Target :

  Drug Metabolite

• Related Pathways :

  Metabolism

• Bioactivity :

  Hydroxy tipelukast (Compound MN-002), a metabolite of Compound MN-001, is an orally active phenoxyalkyl carboxylic acid. It inhibits hepatic steatosis, lobular inflammation, hepatocellular ballooning, and liver fibrosis, while also reducing hepatic hydroxyproline levels. Hydroxy tipelukast is a promising candidate for the study of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) .

• Smiles :

  O=C(O)CCCOC1=C(C(OCCCSC2=CC=C(C(=O)C)C(O)=C2CCC)=CC=C1C(O)C)CCC

• Molecular Formula :

  C29H40O7S

• Molecular Weight :

  532.689

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1027597-04-1